
Overview
Dr. Singhal is a board-eligible urologic oncologist who specializes in the management of patients with kidney, prostate, bladder, testis, upper tract urothelial, and penile cancers. He completed his residency training in urology at the University of Michigan in Ann Arbor, MI, and his research fellowship training in translational science at the University of Michigan. He then completed his clinical urological oncology fellowship at the Mayo Clinic in Rochester, MN. He performs advanced open, endoscopic, laparoscopic, and robotic surgery. Dr. Singhal’s research interests include the development and implementation of novel, precision-based diagnostics and therapeutics in all genitourinary malignancies. He has a special interest in the integration of genomics into biomarker-driven clinical trials in oncology, with the goal of optimally defining the clinical application of these tests. He has received grant funding for his research from the National Institutes of Health, National Cancer Institute, Prostate Cancer Foundation, Urology Care Foundation, University of Michigan, and industry partners. He has additionally received top honors and awards for his research from the Prostate Cancer Foundation, Urology Care Foundation, American Society of Clinical Oncology, and American Association for Cancer Research. He also serves as peer reviewer for many leading academic journals and is a member of numerous professional societies, including the American Urological Association, Society of Urologic Oncology, SWOG Cancer Research Network, SUO Clinical Trials Consortium, and the American Society of Clinical Oncology.
Dr. Singhal is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Choriocarcinoma, Teratoma of the Mediastinum, Prostatectomy, and Nephrectomy.
He is actively involved in clinical research, co-authoring 49 peer reviewed articles. Dr. Singhal is currently accepting new patients.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- POS
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
7500 Challis Rd, Entrance1, Level 1, Brighton, MI 48116
Additional Areas of Focus
Dr. Singhal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Taubman Center
Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries. Dr. Dauw is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Enlarged Prostate (BPH), Perirenal Abscess, Ureteroscopy, and Lithotripsy. Dr. Dauw is board certified in Urology. Dr. Dauw is currently accepting new patients.
Rogel Cancer Center
Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology. Dr. Morgan is currently accepting new patients.
Urology Clinic
J. Quentin Clemens, MD, has published over 200 peer-reviewed manuscripts and book chapters. His research focuses on epidemiology and health services research related to benign urologic diseases, health policy, and quality of care assessment in urology. He has had continuous funding from the NIH since 2001. Dr. Clemens is currently the Principal Investigator for two NIH-funded research networks – the University of Michigan LURN Research Site and the University of Michigan MAPP Research Network. He has served as the Chair of the MAPP Network since 2013. His clinical interests include female urinary incontinence, complex fistulas and erosions, lower urinary tract reconstruction using bowel segments, bladder dysfunction due to neurologic disease, video urodynamic evaluation of complex lower urinary tract dysfunction, and interstitial cystitis/painful bladder syndrome. Dr. Clemens is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Interstitial Cystitis, Frequent or Urgent Urination, Neurogenic Bladder, Sacral Nerve Stimulation, and Reconstructive Urology Surgery. Dr. Clemens is board certified in Urology and Female Pelvic Medicine & Reconstructive Surg. Dr. Clemens is currently accepting new patients.
Urology Clinic
I came to the University of Michigan as a Robert Wood Johnson Clinical Scholar in 1997, following the completion of my urologic training at Cornell University-New York Hospital. During the fellowship, I also obtained a Masters degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health. Even more importantly, I was inspired by my mentors including Rodney Hayward and James Montie to train others to conduct high quality research. I then stayed on to join the University of Michigan faculty as an Assistant Professor in 1999. In 2004, I was promoted to Associate Professor, and in 2009, I was promoted to Professor of Urology. Dr. Wei is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Enlarged Prostate (BPH), Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Wei is board certified in Urology. Dr. Wei is currently accepting new patients.
Rogel Cancer Center
Khaled Hafez is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Hafez is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Hafez is board certified in Urology. Dr. Hafez is currently accepting new patients.
Rogel Cancer Center
Brent K. Hollenbeck, M.D., M.S. is a practicing urologic oncologist and has been on faculty at the University of Michigan since 2003. A graduate of the Indiana University School of Medicine, Dr. Hollenbeck completed his residency in urology and fellowship training in oncology at the University of Michigan. During the past 5 years, his clinical practice has grown in patient volume, which complements his research imperative. Over this time, he has become increasingly specialized in the care of patients with prostate and bladder cancers. This focus has afforded him the ability to maintain his commitment to research while continuing to deliver cutting-edge, high quality care.Dr. Hollenbeck is currently an Associate Professor of Urology and the Director of the Herbert H. and Grace A. Dow Division of Health Services Research at the University of Michigan. He is firmly committed to training the future leaders in urologic health services research. Further, he strongly believes that populating the surgical specialties with health services researchers will yield long-term benefits to both our specialty and our patients.When he is not engaged in clinical and research pursuits, Brent is a very active swimmer, runner and fly fisherman (especially for steelhead). Perhaps most importantly, however, he enjoys spending the bulk of his free time with his wife and two daughters. The Hollenbecks are avid fans of Michigan athletics and look forward to cheering on the Wolverines on football Saturdays. Dr. Hollenbeck is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Hollenbeck is currently accepting new patients.
Frequently Asked Questions about Dr. Udit Singhal
How do I make an appointment with Dr. Udit Singhal?
You can book an appointment with Dr. Udit Singhal by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Udit Singhal a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Udit Singhal is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Udit Singhal specialize in?
While Dr. Udit Singhal is a Urology, they have specific expertise in Prostate Cancer, Prostatectomy, and Choriocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Udit Singhal participate in research or clinical trials?
Yes. Dr. Udit Singhal has published 49 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Udit Singhal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Udit Singhal accept my insurance?
Dr. Udit Singhal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ChoriocarcinomaDr. Singhal isAdvanced. Learn about Choriocarcinoma.
- Prostate CancerDr. Singhal isAdvanced. Learn about Prostate Cancer.
- ProstatectomyDr. Singhal isAdvanced. Learn about Prostatectomy.
- Experienced
- Bladder CancerDr. Singhal isExperienced. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Singhal isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Singhal isExperienced. Learn about Clear Cell Sarcoma.
- CystectomyDr. Singhal isExperienced. Learn about Cystectomy.
- Erectile Dysfunction (ED)Dr. Singhal isExperienced. Learn about Erectile Dysfunction (ED).
- Familial Prostate CancerDr. Singhal isExperienced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Singhal isExperienced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Singhal isExperienced. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Singhal isExperienced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Singhal isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- PriapismDr. Singhal isExperienced. Learn about Priapism.
- Reconstructive Urology SurgeryDr. Singhal isExperienced. Learn about Reconstructive Urology Surgery.
- Renal Cell Carcinoma (RCC)Dr. Singhal isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Scrotal SwellingDr. Singhal isExperienced. Learn about Scrotal Swelling.
- Teratoma of the MediastinumDr. Singhal isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Singhal isExperienced. Learn about Testicular Cancer.
- UPJ ObstructionDr. Singhal isExperienced. Learn about UPJ Obstruction.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Singhal isExperienced. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- UreteroceleDr. Singhal isExperienced. Learn about Ureterocele.
- Urothelial CancerDr. Singhal isExperienced. Learn about Urothelial Cancer.
- Wilms TumorDr. Singhal isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Singhal isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.




